By Sindhu Sundar ( October 1, 2013, 3:42 PM EDT) -- Novartis Pharmaceuticals Corp. on Monday fought a cross appeal by plaintiffs who had won a $250,000 jury verdict in March over a bone disease allegedly caused by the Swiss drug giant's cancer-related bone damage drug Zometa but are seeking punitive damages that the jury declined to award them....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.